What are the etiology, clinical features, and step‑by‑step management of hypercalcemia in pediatric patients?

Hypercalcemia in Pediatrics: Etiology, Clinical Features, and Step-by-Step Management

Begin management immediately with aggressive IV hydration (normal saline at 1.5-2 times maintenance) while simultaneously investigating the underlying cause, as hypercalcemia in children is a potentially life-threatening condition requiring urgent intervention regardless of etiology.

Etiology

Pediatric hypercalcemia has distinct age-related patterns that guide diagnostic approach:

Newborns and Infants

• Genetic causes dominate (70% have germline mutations) 1
• CaSR pathway defects account for 94% of genetic cases in this age group 1
  • Heterozygous CaSR mutations → Familial Hypocalciuric Hypercalcemia (FHH) - typically mild
  • Homozygous CaSR mutations → Neonatal Severe Hyperparathyroidism (NSHPT) - life-threatening
  • GNA11 and AP2S1 mutations also implicated
• Maternal vitamin D deficiency can aggravate neonatal hyperparathyroidism 1
• Iatrogenic causes from blood transfusions 2

Children and Adolescents

• Parathyroid cell proliferation defects (69% of genetic cases) 1
  • MEN1, CDKN1B, CDKN2B, CDKN2C, CDC73, RET, GCM2 mutations
  • Single or multiple parathyroid adenomas
• Malignancy is a major cause 2, 3
  • Tumors account for 43% of hypercalcemic crises 2
  • Most common: neuroblastoma, rhabdoid tumor, hepatoblastoma, rhabdomyosarcoma 3
  • Hematologic malignancies (Hodgkin lymphoma, ALL, acute promyelocytic leukemia) 4
• Iatrogenic (51.7% in one cohort) - most common overall but typically mild 5
• Vitamin D toxicity, granulomatous disorders, endocrinopathies 6

Clinical Features

Severity Classification by Calcium Level

• Mild-Moderate: <3.2 mmol/L (12.8 mg/dL) - often asymptomatic (50% in infants) 1
• Severe: >3.5 mmol/L (14 mg/dL) - typically symptomatic 1
• Hypercalcemic Crisis: Mean 4.6 mmol/L (18.4 mg/dL) - life-threatening 2

Age-Specific Presentations

Newborns/Infants:

• Poor weight gain, feeding difficulties, vomiting 1
• Hypotonia and fractures 1
• Severe cases: polyuria with dehydration, seizures, altered consciousness 1
• Thoracic deformities, nephrocalcinosis 1

Children/Adolescents:

• 80% are symptomatic with severe hypercalcemia 1
• Renal complications (nephrocalcinosis, urinary stones) 1
• Acute abdomen presentation mimicking appendicitis (colicky pain, vomiting) 7
• Bone pain, osteoporosis, pathologic fractures 6
• Psychiatric symptoms in older children 6
• Lethargy, constipation, polyuria 6

Critical Pitfall

Hypercalcemia can masquerade as acute surgical abdomen - always check calcium in children with unexplained gastrointestinal symptoms before considering invasive procedures 7.

Step-by-Step Management

Step 1: Immediate Stabilization (First 24 Hours)

For ALL hypercalcemic children, regardless of cause:

1. Aggressive IV hydration - cornerstone of acute management

   • Normal saline at 1.5-2 times maintenance rate
   • Goal: restore intravascular volume and enhance renal calcium excretion
   • Monitor fluid status closely to avoid overload

2. Add loop diuretics (furosemide) ONLY after adequate hydration

   • Enhances calciuresis
   • Never give before volume repletion

3. Discontinue calcium-containing products

   • Stop vitamin D supplementation
   • Avoid calcium-containing IV fluids
   • Review all medications

Step 2: Severity-Based Pharmacologic Intervention

For Severe Hypercalcemia (>3.5 mmol/L or symptomatic):

Immediate additional therapy:

1. Calcitonin (salmon) - fastest onset (4-6 hours)

   • First-line for rapid calcium reduction
   • Used successfully in hypercalcemic crises 2, 7
   • Tachyphylaxis develops after 48 hours

2. Bisphosphonates (Pamidronate) - within 24 hours

   • Inhibits bone resorption
   • Effective in crises and tumor-related hypercalcemia 2, 7, 4
   • Caution: Variable efficacy in neonates; can cause rebound PTH elevation 1
   • Takes 2-4 days for full effect

For Neonatal Severe Hyperparathyroidism (NSHPT):

1. Calcimimetics (Cinacalcet) - preferred over surgery in 2025
   • Successfully used in multiple severe neonatal cases 1
   • Makes CaSR more sensitive to calcium
   • Most effective for heterozygous CaSR mutations
   • Much less effective for bi-allelic mutations 1
   • Has largely replaced surgical parathyroidectomy as first-line 1

Step 3: Diagnostic Workup (Concurrent with Treatment)

Obtain simultaneously on SAME blood sample:

• Total and ionized calcium
• PTH (essential) 8
• Phosphate (low in PTH-dependent; mean 3.7 mg/dL vs 4.9-5.3 mg/dL) 5
• Albumin (for correction)
• Creatinine
• 25(OH) vitamin D (mandatory to exclude deficiency-induced secondary hyperparathyroidism) 8

Calculate:

• Fractional excretion of calcium (FeCa) 8

  • 2% indicates primary hyperparathyroidism

  • <1% suggests FHH
• Calcium/phosphate ratio: >3.56 (mg/L) or >2.75 (mmol/L) suggests PHPT 8

24-hour urine:

• Calcium excretion
  • Hypercalciuria: >0.1 mmol/kg/day (4 mg/kg/day) in children 8
  • Relative hypocalciuria suggests FHH

Imaging:

• Thyroid/parathyroid ultrasound
• Consider CT if adenoma suspected 7
• Skeletal survey if bone involvement suspected
• Tumor workup if malignancy suspected

Genetic testing:

• Mandatory in all neonates/infants with hypercalcemia 1
• Parental genotyping required for severe neonatal forms for genetic counseling 1
• Consider in children/adolescents with PHPT (40% have mutations) 1

Step 4: Etiology-Specific Definitive Management

PTH-Dependent (Elevated PTH with hypercalcemia):

• Parathyroid adenoma: Surgical excision (parathyroidectomy) 7

  • First-line definitive treatment
  • Monitor for hungry bone syndrome postoperatively (severe hypocalcemia) 7
  • Calcium and PTH normalize within 24 hours 7

• NSHPT with CaSR mutations: Calcimimetics (cinacalcet) 1

  • Surgery now rarely needed
  • Long-term medical management preferred

• FHH (heterozygous CaSR): Usually no treatment needed

  • Benign condition
  • Avoid unnecessary parathyroidectomy

PTH-Independent (Suppressed PTH):

• Malignancy-related: Treat underlying cancer 2, 3, 4

  • Chemotherapy for hematologic malignancies
  • Tumor resection/debulking for solid tumors
  • Supportive care with bisphosphonates and calcitonin
  • Median time to hypercalcemia: 5.4 months after diagnosis 3

• Vitamin D toxicity: Discontinue supplementation

  • Hydration and bisphosphonates if severe

• Iatrogenic: Remove offending agent

  • Usually mild and self-limited 5

Step 5: Refractory Cases

If calcium remains dangerously elevated despite above measures:

• Hemodialysis - most effective for life-threatening hypercalcemia 2
  • Used successfully in hypercalcemic crises
  • Consider when calcium >4.5 mmol/L (18 mg/dL) or renal failure present

Step 6: Monitoring and Follow-Up

Acute phase:

• Calcium every 4-6 hours until stable
• Daily electrolytes (phosphate, magnesium)
• Fluid balance

Post-treatment:

• Watch for postoperative hypocalcemia after parathyroidectomy 7
• Long-term calcium and PTH monitoring
• Renal ultrasound for nephrocalcinosis
• Bone density assessment if prolonged hypercalcemia

Critical Clinical Pearls

Key Diagnostic Distinctions:

• Iatrogenic causes have lowest calcium levels (median 11.6 mg/dL) and are usually asymptomatic 5
• PTH-dependent causes have lowest phosphate (mean 3.7 mg/dL) 5
• Tumor-related has highest mortality (50% poor prognosis) 2
• Age matters: Infants = CaSR defects; Adolescents = adenomas/MEN 1

Treatment Evolution:

• Calcimimetics have revolutionized neonatal NSHPT management, replacing surgery as first-line 1
• Bisphosphonates remain effective but have variable neonatal response 1

Don't Miss:

• Always measure PTH with calcium on same sample 8
• Screen for hypercalcemia in ALL newly diagnosed pediatric malignancies 4
• Genetic testing is not optional in neonatal hypercalcemia 1
• Acute abdomen may be hypercalcemia, not appendicitis 7